Biomarin Pharmaceutical BMRN Earnings Call Transcripts

NASDAQ BMRN
$57.13 -0.05 (-0.09%)
At close: Nov 10, 2026 · 4:00 PM EST
13 earnings calls on file for Biomarin Pharmaceutical, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Biomarin Pharmaceutical Q3 2026 Earnings Call

Nov 2, 2026 9,547 words · 42 min read
  • Traci McCartyHead of Investor Relations
  • Alexander HardyChief Executive Officer
  • Cristin HubbardChief Commercial Officer
  • Gregory FribergChief R&D Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Biomarin Pharmaceutical Earnings Call Transcripts

Calls13
LatestNov 2, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 13 Biomarin Pharmaceutical transcripts Register to get access to Biomarin Pharmaceutical’s earnings call transcripts.